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OKA ~ and CL-A sisnilicantly inhibit he ability of angiotensin It,ATP and vasopressin to raise [Ca2"]~ inrat hepatocytes, with a partial inhibition 
of the initial spike, and a complete inhibition of the following plateau. Incontrast, the [Ca:~ response tothapsigargin, which releases intracellular 
~Icium stores through a mechanism independent of inositol phosphates, is much less affected. The ability of angiotcnsin i I to stimulate lns(l,4,SlP~ 
production is also reduced by OKA, with kinetics consistent with the inhibited lCa'-*]~ response. Since OKA and CL.A are potent and selective 
inhibitors of phosphoprotein phosphatases, these results provide further evidence that a~'.onist.stimulated lns(l,4,5)P~ signalling can be inhibited 
by protein phosphorylation. 
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1. INTRODUCTION 
Stimulation of hepatocytes with angiotensin II or 
vasopressin leads to production of lns(1,4,5)P3 [I,2], 
increased [Ca2+]~ [1--4], and increases in the phosphory- 
lation state era number of proteins [3,5], many of which 
have been identified as putative substrates for either 
protein kinase C [5] or calmodulin-dependent protein 
kinases [6]. In many systems° the ability of agonists to 
induce such responses i inhibited by prior activation of 
protein kinase C, leading to the hypothesis that there 
may be a feedback inhibition of this signalling pathway 
[7]. In hepatocytes0 for example, responses to both epi- 
dermal growth factor [1,3] and phenylephrine [4,8--11] 
are completely blocked by pretreatment with phorbol 
diesters. The mechanism for this phorbol ester-induced 
non-responsiveness may well be desensitization of the 
relevant receptors through a protein kinase C-depend- 
ent phosphorylation event [9,10,12,13]. The ability of 
angiotensin II and vasopressin to stimulate Ins(1,4,5)P3 
production and increases in [Ca'-qa is, however, largely 
resistant o the prior activation of protein kinase C by 
phorbol esters [1,3,4,9,11], although a small degree of 
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inhibition can be revealed at low concentrations ofthese 
agonists [1,4,9,1 ]. 
OKA and CL-A are two potent and selective inhib- 
itors of phosphoprotein phosphatases types 1 and 2A 
[14,15]. OKA treatment has been shown to increase the 
phosphorylation state of many hepatocyte phospho- 
proteins [i 6]. In our preliminary experiments (J.C. Gar- 
rison, unpublished observations), OKA and CL-A 
clearly increase the phosphorylation of two phospho- 
proteins identified as substrates for protein kinase C 
beyond that which occurs with maximal phorbol diester 
treatment. In particular, the phosphorylation state of 
the protein previously designated as "'spot b" [5], with 
a pl = 5.7 and Mr = 56 000, is much greater following 
OKA or CL-A treatment than has been obselwed with 
agonists or phorbol diesters. This result suggested that 
OKA and CL-A may be able to mimic certain effects of 
phorbol esters, but with greater efficacy. In view of the 
very slight effects of phorbol esters upon angiotgnsin 
II-dependent Ca 2. signalling [1,9], it was hypothesized 
that OKA and CL-A may induce significant inhibition 
of these responses. In support of this hypothesis, 
Garcia-Sainz et at., have recently reported that l btM 
OKA is able to inhibit angiotensin ll-stimulated phos- 
phoinositid¢ turnover in rat hepatoeytes [17], although 
effects on [Ca~*]~ levels were not reported. Our results 
show that both OKA and CL-A, at nanomolar con- 
centrations, are able to inhibit the ability of angiotensin 
II to raise [Ca2*]A, and that OKA is also able to inhibit 
angiotensin ll-stimulated increases in Ins(l,4,5)P3 with 
kinetics appropriate to its inhibition of the [Ca2"]j 
response. These results provide further evidence that 
this signalling pathway can be inhibited by protein 
phosphorylation. 
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2. MATERIALS  AND METHODS 
Rat hepatocytos were isolated as described [18] and maintained 
under 95% O~,/5% CO_, for all subsequent procedures. For measure. 
ment of [Ca:+]~, hepatocytes at 2 x 106 cells/ml were preincubated in 
the dark in KRB containing 0.5 mM Ca:* and supplemented with 20 
mM HEPES, 1 mg/ml ¢BSA, 5 mM glucose, 5 mM pyruvateo and 20 
mM lactate for 15 rain at 37°C. Aliquots (2,5 ml) were withdrawn onto 
ice for autofluorescenc¢ controls and kept in the dark. The remaining 
cells were loaded with indo-I by addition of 10 /~M indo-I 
tctrakisaeetoxymethyl~ster for a further 30 mln incubation at 37°C. 
The ceils were pelleted (5 rain, 50 ×g), the medium aspirated and the 
bepatocytes resus~nded in supplemented KRB and aliquoted as 
before. Aliquots of cells were warmed to 37°C with gentle shaking in 
the presence ofOKA, CL-A or the DMSO vehicle control for 30 min. 
The cell~ were then gently pullct~d, resuspended in fresh, supple- 
mented KRB and placed into a stirred cuvette maintained at 37"C in 
an SLM-8000 spectrofluorometer. The dye-loaded c¢11~ were excited 
at 332 rim, and fluorescence was recorded at 1 s intervals at both 400 
nm and 485 rim. Agonists were added from 100-fold concentrated 
stocks in either 20 mM Tris-HCl, pH 7.4, plus 1 mg/ml cBSA (angio- 
tensin I1, vasopressin, ATP) or in 2% (v/v) DMSO in Tris.HCI/BSA 
(thapsigargin) to give the final con~ntrations shown in Table I. Max- 
imal and minimal fluorescence were defined by addition of 30 pg/ml 
digitonin and 5 mM EGTA, pH 7.5, respectively, Since the autolluo- 
reseence of the cells is not negated uring the calculation procedure 
for dual wavelength dye responses [19], the autofiuoreseence of cells 
not loaded with dye but otherwise treated equivalently was subtracted 
at both wavelengths prior to conversion of the data to apparent [Ca:']~ 
through the use of the formula given by Grynkiewicz et el. [19], 
To quantitatively compare response, basal [Ca:*]t was defined as the 
mean of the calculated values for the 30 s prior to agonist addition, 
and the plateau increase in [Ca:÷]~ was defined as the mean calculated 
value between 60 and 90 s after agonist addition minus the basal evel. 
To analyse the [Ca:+]j transient, the release of Ca -~+ into the cytosol was 
fiL tO a model originally developed to analyse the episodic secretion 
of pituitary hormones that underlies the pulsatile concentrations of 
those hormones in plasma [20]. The analysis fitted the data to both the 
release of Ca -~÷ and its simultaneous removal by developing a convolu- 
tion integral that was solved by iterative nonlinear least-squares pa- 
rameter estimation, in which all values of [Ca:÷]~ and their variances 
were considered simultaneously [20l. The peak increase in [Ca~*]t was 
defined as the mean increase over the basal evel achieved for the 5 s 
around the time point predicted for the peak by the program. OKA 
did not change the position of the peak responses. For example, the 
m,~an time to peak followins angiotensln II stimulation (Fig. 1, Table 
I) was 19 ± 2 s in the control, and 14 +_ 2 s in OKA.treated cells; 
following thapsigargin .stimulation, mean time to peak was 36 -+ 4 s 
in the control, and 40 _+ 6 s in OKA-treated cells. Therefore, for the 
few records that could not be fit with the program, the p0ak could be 
defined by inspection of the data at these predicted positions. 
Measurements of inositol phosphates were performed as previously 
described [1,21], Suspensions of hepatoeyte~ at 3-5 x 10 ~ cells/ml were 
labelled with 30/aCi/ml [l,2.alfl.rnyo.inositol (35 CVmmol) in KRB 
supplemented with 2 mg/ml cBSA, 10 mM glucose, 16 mM lactate, 4
mM pyruvate, 10 tiM myo-inosltol for 90 min at 37°C, Cells were 
pelleted, rinsed in KRB supplemented with 5 pM myo.inositol, and 
then r~uspendod in KRB and aliquoted on ice. Aliquots were warmed 
to 37'C with f~entle shaking in the presence of 300 nM OKA or its 
DMSO vehicle for 30 rain. The cells wer~ then ~timulated with angio- 
retain I1 and ac~.d extracts prepared for HPLC analysis as described 
[1]. Separation of inositol phosphates by strong anion-exchange 
HPLC was performed as d~r i l~d [21], w~th monitoriu~ of the eluate 
either by collection of fractions lbllowed by scintillation counting [1 ], 
or t,y an on-line radioactivity d~t~etor (Radiomatic Flo-On~ fl A250) 
[21]. For most experiments he on-line detector was used, allowing the 
full spectrum of inositol metabolitos to be recorded [21]. In those 
experiments, presented in Fig. 3, the yield of inosltol trisphophates was 
normalized to 100 000 cpm total content o control for slight varia- 
tions in the cell counts, labelling intensity and recovery. The use of the 
on.line detector does, however, lead to a loss of absolute sensitivity, 
since the apparent background is higber and the efficiency of counting 
is lower tha,a can be attained in a conventional scintillation counter 
(RRM and 3GG, unpublished observations). Thus l'or the dose- 
response xperiments (Fig. 2), where sub.maximal responses were 
quantitated, fractions were collected and counted in a liquid scintilla- 
tion counter. 
To assay for lns(l,4,5)P~ 3-kinase activity, samples oF cytosol from 
stimulated hepatocytcs were prepared by a modification of the method 
of Biden ct el. [22]. Briefly, hepatocytes were treated ~vith 300 aM 
OKA for 13 rain at 37°C, rapidly pelleted, and the supernatant 
aspirated. The pellet wa.~ suspended in l ml of 10 mM KCI/10 mM 
HEPES and left on ice for 10 rain. Saturated KCI was added to restore 
iso-osmolarity, and the cells homogenized in a.;.ight-fit gins= Do-nee 
homogenizer. Tile ~uspension was cleared at 1O0 000 × g for 1 h. and 
the supernatant used as a cytosolic extract. Ins(lo4,5)P~ 3-kinase activ- 
-~ty was assessed in reactions of 25-50/.tg cytosolie protein with 1-10 
/~M Ins(l,4,5)P~ for 60 s at 25°C in the manner described [23]. 
Statistical significance was assessed by the one-tailed, paired t.test. 
Silgnoid curves were fitted to the data in Fig. 2 by non-linear regres- 
sion using the software GraphPad lnPlot. 
Turnout promoters (OKA, CL-A and thapsigargln) were obtain~ 
from LC Service Corporation, Woburn MA. DMSO (puriss. p.a. 
grade) was from Fluka Chemical Corporation, Ronkonkoma, NY. 
Th~ sources of all other eagents have previously been given [1,21,24]. 
3. RESULTS 
In  order  to  test the hypothes is  that  OKA may cause 
signif icant inhib i t ion o f  angiotens in  I I -dependent  
signal l ing, the abi l i ty  o fang io tens in  I I to increase [Ca>]~ 
in hepatocytes  was assessed fo l lowing pret reatment  with 
OKA.  Fig. I A demonst ra tes  that  100 nM angiotensin 
1I is able to produce  a s imi lar spike and  p la teau  increase 
in [Ca~-*]~ in hepatocytes  loaded wi th  indo-1 as com- 
pared  to those repor ted to  occur  in cells loaded with 
either quin-2 [1,3] o r  f lue-3 [25]. I t  is clear f rom panels 
B and  C o f  Fig, 1 that  OKA is able to produce  a dose- 
dependent  inh ib i t ion of  the response to th is  maximal  
dose o f  angiotens in  II, This  result thus d ist inguishes the 
inh ib i tory  act ion o f  OKA f rom that  o f  phorbo l  esters, 
since we have prev ious ly  shown that  phc, rbo l  esters are 
on ly  able to  block the [Ca2÷]~ responses to low doses (~- 
0,1 r iM) o f  angiotens in  I I  [1]. 
To  further  invest igate the inh ib i tory  effect o f  OKA 
upon angiotens in  I I - s t imulated increases in [Ca-~÷]~, this 
effect was quant i ta ted  f rom several  exper iments ,  and 
compared  with ti le effects o f  OKA and CL -A  upon the 
ab i l i ty  o f  o ther  agonists  known to raise [Ca2÷]~ in hepat-  
oeytes  (Table  I). Both  OKA and CL -A  produce  signif- 
icant  part ia l  inh ib i t ion o f  the magn i tude  o f  the initial 
sp ike response to angiotens in  1I, but  there  is a more 
dramat ic  effect upon the later  p la teau  reslaonse~ which 
is complete ly  abol ished.  A very s imi lar  pat tern  is seen 
in cells s t imulated  with vasopress in  or ATP ,  two  other 
agonis ts  that  a lso raise [Ca2"]~ in hepatoc2/tes through 
the generat ion  o f  inositol  -~.^,_k  . . . .  re 0,~1 
Thaps igarg in ,  which inhibi ts  the Ca2÷-ATPase o f  sar- 
cop lasmic  ret icu lum [27] and  the endoplasrn ic  ret ieulum 
o f  hepatocytes  [28], causes a slow, susta ined increase in 
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hepatocyte [CaV]~ through mobilization of intracellalar 
stores that include those mobilized by lns{1A,5)P~ [28]. 
In contrast to the responses to those agonists that 
retease calcium from these stores subsequent o 
lns(l A,5)P~ production, the sustained increase in [Ca2*L 
induced by thapsigargin is much less sensitive to pr,;- 
treatment with OKA of CL-A (Table 1). 
Since OKA and CL-A appear more abl~ to inhibit the 
increases in [Cal+]~ induced by agents acting through 
Ins(I,4,5)P~ production, this suggested that the m~ha- 
nism might involve an inhibition of  the production or 
action of lns(l,¢,5)P~. The ability of angiotensin II to 
stimulate the production of Ins(1,4,fi)P~ following pre- 
treatment with OKA is shown in Fig. 2, OKA induces 
a decrease in the stimulated accumulation of 
ias(l,4,fi)P 3in response to the full range of angiotensin 
II concentrations. To further investigate th¢ connection 
between the OKA-induced inhibition of  the Ins(l,4,5)P~ 
response to angiotensin il and the inhibition of the 
[Ca~*]~ response to angiotensin II, the effects of OKA on 
the kinetics of  inositol phosphate production were in- 
vestigated (Fig. 3). Fig. 3A shows that the kinetics of the 
Ias(l,4,5)P3 response to angiotensin II demonstrate he 
same initial spike and later plateau characteristics a are 
seen in the [Ca2*l~ response (compare Fig. 1A with Fig. 
3A). OKA pretreatment is able to reduce the initial 
spike of  lns(t,4,5)P~ arm to almost completely abolish 
the later plateau response (Fig, 3A), again consistent 
with the OKA-inhibited [Cal"]~ r=sponse to angiotensin 
II (Fig. IC), The fact that OKA treatment is able to 
reduce the total accumulation of inositol phosphates in
r~sponse to angiotensin II (Fig. 3C) is consistent with 
an OK.A-dependent inhibition of the production of 
las(1,4,5)P~. 
The ability of angiotensin 11 to stimulate the ac- 
cumulation of ins(I,3,4)P~ is shown in Fig. 3B. It is 
apparent that, at least at the early time points of 
stimulation, the appearance of Ins(1,3,4}P~ is largely 
insensitive to pretreatment of the cells with OKA. This 
is surprising since Ins(l,3,4)P~ is produced from 
Ins(l,4,5)P~, through the sequential actions of 3-kinase 
Table l 
OKA and CL-A inhibition of agonist-indueed incr~mc~s in [Ca:']~. E~perimcnts s ub as tho~ shown in Fig. I were qamatitai~d  escribed in Section 
2. Data arc mean :1: g.E.M. (= $.D. when  -- 2) from th~ number of independent ra  hepato¢lit ,~ prepamtlons shown in parcnthe~2~. Basal [Ca~']L 
levels were: 20l :~ 16 nM in the control h~p:ttocytes; 266 -'I- 19 nlM re|lowing OKA treatment; 273 ± 31 nM following CL-A treatment 
Poak inorea~ in ICa'+]j over basal (riM} Plateau increaz¢ in [Cal"], o~er basal {aM) 
Agent Control (DMSO} 300 nM OKA 100 nM CL-A Control (DMSO} 300 nM OKA 100 nM CL-A 
pretreatment pretreatment pretr~atmeat pretreatment prctreatment pmtre, atmcnt 
I{20 nM Ang[otensin II 199 +- 46 {~,) 95 _+ 22" ('~) 19 _-L" liP (.3) 72. + 20 {8~ -0.6 _ 17" (7) .-45 _+ 20" {3) 
I00 nM VasopPssin 2.29 ~ fi4 (3) 38 = 30" (3) 39 _ 2' {311 66 "~ 25 (3) 3 _ 16 b (3} --44 ± 25" {3) 
IOO #'M ATP I(~9 ± 49 (3) 40+_15'(3) 45 ± 20b(3) 52±22(3)  -22_ 16" (3) -29 ± 9" (3) 
200 nM Thap~igsrgin 173 _ 37 (6) 98 :t 21' (6) 109 ± 6 (2} 130 =[: 39 (6) 83 :t: 33' (6) 75 ± L7 t' {2) 
"Reduced from control (DMSO)  mspon~ {P < 0.05); breduced from comrol {DMSO)  r~poasc {0.20 > P > 0.05). 
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Fig. 2. Okadalc acid pretreatlnent inhibits angiotensln.stimulated 
production of lns(l.4,5)P.~. Angiotensin II stimulates the production 
of lns(l,4,5)P~ with varying kinetics at different a~onist concentra- 
tions [1]. For these experiments, angiotensin stimulation was ter- 
minatexl at 30 s, since this protocol gives close to the maximum 
response throughout he concentration range. Data are mean _+ 
S.E.M. from 4 independent experiments. The reduction inductxt by 
OKA (30 mix at 300 nNl) was zignificant (P < 0.0fi) at all ane, iote,asin 
11 concentrations, includin 8 the zero angiotensin control (data: reduc- 
tion from 91 _+ 8 cpm to 68 + 10 cpm), 
and 5-phosphatase enzymes [29], and thus would be 
expected to show a similar pattern of reduced accumula- 
tion as does Ins(l,4,f)P3 following OKA pretreatment. 
Yet at these early time points, when lns(l,4,5)P.~ ac- 
cumulation is significantly reduced (Fig. 3A), 
Ins(l,3,4)P3 accumulation is not (Fig. 3B). This suggests 
that there may be stimulated metabolism of Ins(1,4,5)P3 
through the 3-kinase pathway to maintain the levels of 
Ins(l,3,4)P~ despite reduced amounts of its precursor, 
Ins(1,4,5)P~. Further, OKA-induced inhibition of 
Ins(1,3,4)P~ accumulation is only seen at later time 
points (Fig. 3B) when production of its precursor 
Ins(l,4,5)P~ is almost back to basal levels (Fig. 3A). 
Interestingly, rat liver Ins(1,4,5)P~ 3-kinase has previ- 
ously been reported to be stimulated following activa- 
tion of protein kinase C and cAMP-dependent protein 
kinase [22]. Since OKA is able to increase the phosphor- 
ylation state of many of the same phosphoproteins a  
seen following the activation of such kinases [16], OKA 
treatment might also be expected to activate this en- 
zyme. Indeed, preparation of cytosolic extracts of he- 
patocytes from control and 300 nM OKA-treated cells 
demonstrated a 3.4-fold increase in Ins(1,4,5)P~ 3- 
kinase activity (control = 354 pmol/min/mg protein; 
OKA-treated = 1214 pmol/min/mg protein). This would 
suggest hat in addition to a decrease in Ins(1,4,5)P~ 
production, there may also be increased metabolism of 
Ins(1,4,5)Pzto Ins(1,3,4,5)P4 and thence Ins(l,3,4)Pz in 
the OKA-treated cells. 
4. DISCUSSION 
The role of protein phosphorylation in the control of 
agonist-stimulated Ins(l,4,5)P3 production and signal- 
ling has been further investigated in this study. The 
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Fig. 3. Okadaie acid inhibition of angiotensht ll-stimulated inosJtol 
phosphate accumulation. Data are mean :1: $. E.M. from 5 independent 
experiments with 30 rain of 300 nM OKA prctreatment and 100 nM 
angiotensin il stimulation at zero time. (A) lns(i,4,5)P~ accumulation. 
lns(l,4,5)P, was reduced significantly (P < 0.05) by OKA pretreatment 
at 10, 30, 60 and 120 s time points. (B) Ins(l,3,4)P3 accumulation. 
lns(l,3,4)P.~ was reduced signilicantly (P < 0.05) only at 60 and 120 
s time-point~. (C) accumulation of all inositol phosphates (> 9096 
inosjtol monophosphate and bisphosphate, < 10% InsP.~ and lnsP~); 
reduced significantl~ (P < 0.05) at 10, fi0 and 120 s time-points. 
striking inhibition of angiotensin iI.dependent second- 
messenger responses induced by OKA is far greater 
than the modest effects of phorbol diesters on these 
responses [1,9]. The observation that both OKA and 
CL-A blunt the [Ca-~'l~ response to angiotensin II con- 
firms that the inhibition is likely to be due to increased 
protein phosphorylation, since these agents share the 
ability to inhibit phosphoprotein phosphatases 1 and 
2A [14A5]. Further, the lack of effect of 3 nM OKA 
upon angiotensin II-dependent responses, compared 
with the maximal effect of 300 nM OKA, corresponds 
with the dose-dependence of increases in protein phos- 
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phorylation induced by OKA [16]. Since there are phos- 
phoproteins that show increased phosphorylation i
response to OKA and CL-A beyond that seen in 
response to phorbol diesters (J.C. Garrison, unpub- 
lished), exemplified by the phosphoprotein previously 
designated as "spot b" [5], the identification of these 
phosphoproteins may reveal the sites at which agonist- 
stimulated Ins(1,4,5)P3 signalling can be inhibited by 
phosphorylation. 
In rat hepatocytes, there are two classes of agonists 
that can couple to Ins(l,4,5)P3 production and in- 
creased [Ca'-*]~, first, agonists uch as epidermal growth 
factor and phenylephrine produce characteristically 
small Ins(1,4,5)P3 responses that can be completely in- 
hibited by prctreatment with phorbol diesters [1,3,4,9- 
11], putatively through phosphorylation-induced r - 
ceptor desensitization [9,10,12,13]; second, agonists 
such as angiotensin II and vasopressin produce charac- 
teristicaily large Ins(1,4,5)P3 responses which are largely 
refractory to the action of phorbol diesters, at least at 
maximal agonist doses [1,3,4,9,11]. 
OKA and CL-A are able to dramatically inhibit the 
ability of angiotensin II to raise [Ca~'+]i. Several results 
of this study suggest that the primary effect of OKA on 
the angiotensin II signalling pathway may lie within the 
receptor/G protein/phospholipase C system that 
transduces the angiotensin II stimulus into production 
of Ins(l,4,5)P~. For example, OKA and CL-A seem 
more able to inhibit the increases in [Ca-'+]~ induced by 
agonists that couple through Ins(l,4,5)P~ production, 
and, indeed, angiotensin lI-stimulated lns(l,4,5)P3 ac- 
cumulation is reduced'by OKA with kinetics consistent 
with the inhibited [Ca:+]~ response. The site in the 
signalling machinery that is principally inhibited follow- 
ing OKA treatment is unclear, however. The angio- 
tensin receptor in rat hepatocytes which putatively 
couples to phospholipase C has the characteristics of the 
AT. type [25,30] that has recently been cloned [31,32]. 
The predicted amino acid sequence reveals a number of 
potential phosphorylation sites that could be consistent 
with regulation of receptor function [31,32]. Since there 
is similar inhibition of responses to vasopressin and 
ATP as there is to angiotensin I1 in OKA.treated cells, 
a receptor-specific inhibitory mechanism would imply 
that there are equivalent means to inhibit each of these 
receptor systems. An alternative mechanism that would 
account for the ability of OKA to induce similar inhibi- 
tions of the responses to these agonists would be the 
phosphorylation f a common component of the signal 
transduction pathway subsequent to the receptor. A 
similar conclusion was recently drawn by Garcia-Sainz 
et al., who showed that OKA was able to inhibit phos- 
phoinositide turnover stimulated by angiotensin lI, 
vasoprcssin, epinephrine or mastoparan rl~ t,-J. As yet a 
precise molecular description of the signalling pathway, 
specifying the G protein and phospholipase C isozymes 
concerned, is not available for any of these agonists, and 
thus the site at which OKA acts to inhibit the produc- 
tion of Ins(I,4,5)P3 cannot yet be defined. 
In addition to the ability of OKA to reduce angio- 
tensin II-stimulated Ins(l,4,5)Ps production, it seems 
possible that OKA and CL-A may be able to inhibit 
agonist-induced calcium signalling in at least two other 
ways. First, there may be a change in the intracellular 
calcium pools in hepatocytes treated with OKA or CL- 
A. Such an alteration may be reflected in the small 
increase in basal [Ca-~+]~ seen in OKA- and CL-A-treated 
hepatocytes and may partly explain the reduced 
response to subsequent agonist addition, including the 
partial reduction seen following stimulation with 
thapsigargin (Table I). The increase in basal [Ca'-÷]~ is
not likely to be caused by Ins(l,4,5)P3 since the basal 
level of Ins(1,4,5)P3 is apparently suppressed in OKA- 
treated hepatocytes (Fig. 2). Second, the potential in- 
crease in Ins(l,4,5)P 33-kinase activity in OKA-treated 
cells may also reduce the accumulation of lns(l,4,S)P3. 
The net effect of such an increase in 3-kinase activity 
upon the ability of agonists lo stimulate increases in 
[Ca-'+]i would be difficult to predict, as the product of 
the 3-kinase, lns(1,3,4,5)P4, has also been proposed to 
play a role in calcium signalling [33]. 
In conclusion, we have demonstrated that angio- 
tensin-stimulated lns(1,4,5)P~ and [Ca~']i signalling can 
be inhibited by OKA and CL-A. These agents increase 
the phosphorylation state of numerous phospho- 
proteins in rat hepatocytes by virtue of their ability to 
inhibit the basal actions of phosphoprotein 
phosphatases. These results thus provide further 
evidence that a phosphoprotein may be a component of 
the signalling machinery that transduces the agonist 
stimulus into production of has(l,4,S)P3 and subsequent 
increases in [Ca-'*]~. The observation that the inhibition 
of the angiotensin response is greater than we have 
previously been able to demonstrate with phorbol 
diester pretreatment would indicate that this phospho- 
protein is a substrate for both protein kinase C and 
either phosphoprotein phosphatase 1 or 2A, and that 
increases in the phosphorylation state of this protein 
produce desensitization f the signalling pathway. 
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